Erectile Dysfunction

Then he takes Levitra, and she reappears with a grin ear to ear, a tray of lemonade and her man fires a Brett Favresque pass dead on balls accurate, pun intended, through the tire.) And keep this in mind, the Masters notoriously is known for showing less commercials than other tournaments.

Yet, still we only get a handful of golf shots, most of which are of Tiger Woods while Johnny Miller and Nick Faldo trudge on about why Tiger is in a slump, even though he’s missed one cut in about his last 800 career tournaments, plays once a month in an event he at the very least finishes in the top five, and generally hits golf shots that to him are sub par, but to everyone else are about the most amazing thing to witness this side of Aurora Borealis.

Yeah, that was a reference to Aurora Borealis.

So what?

There are 70 to 80 golfers on the course throughout the weekend of a tournament.

Why are we only shown three golfers?

I know people like Phil and Tiger, but you can’t tell me there aren’t other good shots going on.

Hell, I think the key shot of the entire Masters, Zach Johnson’s chip in for birdie down the stretch, was on tape-delay.

Good work, CBS.

Way to be on top of things.

Getting back to Maxfli’s commercial, why is it alright for Sergio Garcia to appear in Michelob Ultra commercials, but Maxfli can’t advertise to Daly’s beer...

However, maraviroc's label could eventually be extended to newly-diagnosed patients.

Another new drug in late stage development, Merck & Co.'s integrase inhibitor raltegravir, is expected to be filed with the FDA within the next two months.

With an anticipated launch towards the end of the year, it is also most likely to be used in treatment experienced patients.

Since both drugs offer a novel mechanism of action, Datamonitor expects considerable competition between the two.

Nonetheless, their availability will extend treatment options for patients with more advanced HIV and those with AIDS, making them significant contributors to the growth in the HIV market.

'End Intelliext RELATED NEWS Monogram to get $25 million investment from Pfizer9 May 2006 Pfizer: timely response to industry challenges24 Jan 2007 Pfizer: torcetrapib failure compounds current problems5 Dec 2006 Pfizer: a strategic reversal of fortunes?

27 Jul 2006 Pfizer: no immediate threat to Celebrex from generics 22 Mar 2007 COMPANIES MENTIONED Merck & Co., Inc.

Pfizer Inc YOUR OPINION...

Comment on this Article NEWSLETTERS Sign up to our weekly newsletters for the latest industry news & comment.

I would like to receive Business Digest I would like to receive Drug Delivery News I would like to rec...